about
High-throughput loss-of-heterozygosity study of chromosome 3p in lung cancer using single-nucleotide polymorphism markers.Identification of alpha-actinin 4 and 67 kDa laminin receptor as stage-specific markers in esophageal cancer via proteomic approaches.Identification of genes with allelic imbalance on 6p associated with nasopharyngeal carcinoma in southern ChineseOverexpression of GPR39 contributes to malignant development of human esophageal squamous cell carcinoma.Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma.RBMS3 at 3p24 inhibits nasopharyngeal carcinoma development via inhibiting cell proliferation, angiogenesis, and inducing apoptosisCell-specific detection of miR-375 downregulation for predicting the prognosis of esophageal squamous cell carcinoma by miRNA in situ hybridization.Genome-wide gene expression profile analyses identify CTTN as a potential prognostic marker in esophageal cancer.Regulatory role of hexosamine biosynthetic pathway on hepatic cancer stem cell marker CD133 under low glucose conditions.Integrin α7 is a functional cancer stem cell surface marker in oesophageal squamous cell carcinoma.Esophageal squamous cell carcinoma (ESCC): advance in genomics and molecular genetics.Characterization of oncogene-induced metabolic alterations in hepatic cells by using ultrahigh performance liquid chromatography-tandem mass spectrometry.Antitumor activity of a novel small molecule TLR7 agonist via immune response induction and tumor microenvironment modulation.Podoplanin‑positive cancer cells at the edge of esophageal squamous cell carcinomas are involved in invasion.Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.Allele-specific imbalance of oxidative stress-induced growth inhibitor 1 associates with progression of hepatocellular carcinoma.Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.Wnt2 secreted by tumour fibroblasts promotes tumour progression in oesophageal cancer by activation of the Wnt/β-catenin signalling pathway.Characterization of tumor-suppressive function of SOX6 in human esophageal squamous cell carcinoma.Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma.Increased expression of annexin I is associated with drug-resistance in nasopharyngeal carcinoma and other solid tumors.Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer.Frequent concomitant epigenetic silencing of the stress-responsive tumor suppressor gene CADM1, and its interacting partner DAL-1 in nasal NK/T-cell lymphoma.Single-nucleotide polymorphism-mass array reveals commonly deleted regions at 3p22 and 3p14.2 associate with poor clinical outcome in esophageal squamous cell carcinoma.Isolation and characterization of a novel oncogene, amplified in liver cancer 1, within a commonly amplified region at 1q21 in hepatocellular carcinoma.PSCA acts as a tumor suppressor by facilitating the nuclear translocation of RB1CC1 in esophageal squamous cell carcinoma.Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma.FZD7 is a novel prognostic marker and promotes tumor metastasis via WNT and EMT signaling pathways in esophageal squamous cell carcinoma.Down-regulation of tyrosine aminotransferase at a frequently deleted region 16q22 contributes to the pathogenesis of hepatocellular carcinoma.RNA editing of SLC22A3 drives early tumor invasion and metastasis in familial esophageal cancer.BCSG1 siRNA delivered by lentiviral vector suppressed proliferation and migration of MDA-MB-231 cells.Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1l) gene suppresses the nucleus-to-mitochondria translocation of nur77 to sustain hepatocellular carcinoma cell survival.E6 protein expressed by high-risk HPV activates super-enhancers of the EGFR and c-MET oncogenes by destabilizing the histone demethylase KDM5C.Eukaryotic translation initiation factor 5A2 promotes metabolic reprogramming in hepatocellular carcinoma cells.O-GlcNAc transferase promotes fatty liver-associated liver cancer through inducing palmitic acid and activating endoplasmic reticulum stress.Frizzled7 Promotes Epithelial-to-mesenchymal Transition and Stemness Via Activating Canonical Wnt/β-catenin Pathway in Gastric Cancer.MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN.Overexpression of matrix metalloproteinase 10 is associated with poor survival in patients with early stage of esophageal squamous cell carcinoma.Downregulation of RBMS3 is associated with poor prognosis in esophageal squamous cell carcinoma.Frizzled Receptors as Potential Therapeutic Targets in Human Cancers.
P50
Q33240100-810FC588-2DA1-45C8-888C-B1FF54AB4898Q33303882-8BB6B016-7776-428B-856F-ED08D84F417EQ33809442-AF735ADE-3631-47A3-B1CA-A3854604187EQ33830089-7EC5D1FA-920E-49FA-AEAC-0651D698B57DQ34095605-9E90E034-7FAE-4C5D-918E-920CCA5673CFQ34408248-C420C8C7-DE52-4B87-A508-2ABC67A4AA16Q34542564-A430067D-17B5-4CE7-B3B1-1E16A80AEAA0Q35097632-039C69DD-D8C0-46D5-BEA2-EBCA08C8AFD4Q36583430-7848C772-3BFE-4355-9A05-B9107F2E164EQ37493728-81C57324-FE5F-4465-9A08-56D3BED73B89Q38116602-3BB3BAF7-903B-405A-B0A4-9DD32E6D285CQ38785050-5071978C-38C1-48A7-825C-B7B21C3B2952Q38807842-C0D8E20C-69C9-4B50-9ECE-B05E9DF79209Q38983858-14530DC5-D3B2-4C8D-90B4-0BE38DD37A33Q39021687-2C10E2B1-3659-4358-AA32-B6F3F1673C8CQ39034955-A9CD1F65-B366-4102-BD24-9E1B767D3E15Q39330246-73C9067F-776B-44F6-B153-D11BDD6055EAQ39524651-25D8A9AD-FABA-42C3-A0DD-583C8B625E04Q39630589-19B660D8-4929-4306-84B9-13BC26006B62Q39838049-3E4310FB-F879-4E5B-BAFE-2B1D37DC6583Q39845448-871131F8-CE82-414D-BF86-7E28101FD662Q39850176-5414B561-C88A-45BE-BCFB-53658E03E0B0Q39900606-565451E9-E12C-4812-8866-2AC8FD55DE7EQ39977725-C6D20945-3610-4FF4-9C64-D14BFAA7F8F6Q40049355-D121BBF0-0A53-45C9-91A4-425FA1DA1C70Q40088346-FA21AE45-89E8-4A5B-96A4-BE8AF1389418Q42119412-D7F6269C-EAD1-4902-B7D4-F9D17F911F86Q42371598-D3127E9D-15C6-43C7-8766-EF77F858CBC0Q43139836-CBC1636C-A0FE-4092-A508-76D05720230BQ45346268-5F4FE963-E169-4B3D-8195-97947AA23867Q47246570-35FD1ACB-1A5D-4DC6-92EE-C5D42AE78337Q47803497-BE4ACFB9-1D74-4420-ADE2-D287E25C736CQ50020004-2134E114-041F-40FD-A2F8-E6EB3AE7658EQ51049728-2CC7F4C3-703A-4C07-8090-93C339337B6FQ51083627-FB79485D-85EA-49B1-BCFD-E40BC2174387Q52645999-503EC0D3-1BFC-45E2-883C-3CA194E9E8F5Q54284943-37CB91AF-F7F6-40FF-8D77-0E468D832CC8Q54336749-278D73CF-55BE-469D-A2DA-5137A5ABB034Q54567714-8803AF22-5414-45EE-ABB9-21EEAB1C532AQ55080511-DBB955AA-CC29-4172-A692-ABBDF03DFA9D
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Li Fu
@ast
Li Fu
@en
Li Fu
@es
Li Fu
@nl
Li Fu
@sl
type
label
Li Fu
@ast
Li Fu
@en
Li Fu
@es
Li Fu
@nl
Li Fu
@sl
prefLabel
Li Fu
@ast
Li Fu
@en
Li Fu
@es
Li Fu
@nl
Li Fu
@sl
P1053
F-7182-2010
P106
P31
P3829
P496
0000-0003-2643-6278